<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">Prophylactic HIPEC with cisplatin was safe and well tolerated in patients with locally advanced gastric cancer. The survival benefit of HIPEC as a prophylactic therapy for locally advanced gastric cancer patients should be validated by prospective trials in a larger cohort.</p>
